Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pushkar Kulkarni

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Chemical Biology & Drug Design|January 27, 2015
Design and Biological Evaluation of Furan/Pyrrole/Thiophene-2-carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureusRenuka Janupally, Bhramam Medepi, Parthiban Brindha Devi, et al.
Chemmedchem|January 26, 2016
Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase DomainVariam U Jeankumar, Shalini Saxena, Rahul Vats, et al.
Journal of Pharmacological and Toxicological Methods|October 5, 2017
Correlation of pharmacokinetics and brain penetration data of adult zebrafish with higher mammals including humansPushkar Kulkarni, Raghavender Medishetti, Nagaraju Nune, et al.
Chemical Communications (Cambridge, England)|June 5, 2013
AlCl3-mediated hydroarylation-heteroarylation in a single pot: a direct access to densely functionalized olefins of pharmacological interestAli Nakhi, Sivakumar Archana, Guru Pavan Kumar Seerapu, et al.
Bioorganic & Medicinal Chemistry|December 27, 2014
Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitorsVariam Ullas Jeankumar, Sonali Kotagiri, Renuka Janupally, et al.
Organic & Biomolecular Chemistry|January 9, 2015
Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profilingVariam Ullas Jeankumar, Rudraraju Srilakshmi Reshma, Renuka Janupally, et al.
Pharmacological Reports : PR|June 7, 2014
Oral dosing in adult zebrafish: proof-of-concept using pharmacokinetics and pharmacological evaluation of carbamazepinePushkar Kulkarni, Girish Hari Chaudhari, Vijaykumar Sripuram, et al.
Chemmedchem|June 26, 2014
Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analoguesVariam Ullas Jeankumar, Janupally Renuka, Sonali Kotagiri, et al.
European Journal of Medicinal Chemistry|August 30, 2014
Ligand-free Pd-catalyzed C-N cross-coupling/cyclization strategy: an unprecedented access to 1-thienyl pyrroloquinoxalines for the new approach towards apoptosisSunder Kumar Kolli, Ali Nakhi, Sivakumar Archana, et al.
International Journal of Antimicrobial Agents|January 18, 2014
Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leadsVariam Ullas Jeankumar, Janupally Renuka, Venkat Koushik Pulla, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Chemical Biology & Drug Design|January 27, 2015
Design and Biological Evaluation of Furan/Pyrrole/Thiophene-2-carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureusRenuka Janupally, Bhramam Medepi, Parthiban Brindha Devi, et al.
Chemmedchem|January 26, 2016
Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase DomainVariam U Jeankumar, Shalini Saxena, Rahul Vats, et al.
Journal of Pharmacological and Toxicological Methods|October 5, 2017
Correlation of pharmacokinetics and brain penetration data of adult zebrafish with higher mammals including humansPushkar Kulkarni, Raghavender Medishetti, Nagaraju Nune, et al.
Chemical Communications (Cambridge, England)|June 5, 2013
AlCl3-mediated hydroarylation-heteroarylation in a single pot: a direct access to densely functionalized olefins of pharmacological interestAli Nakhi, Sivakumar Archana, Guru Pavan Kumar Seerapu, et al.
Bioorganic & Medicinal Chemistry|December 27, 2014
Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitorsVariam Ullas Jeankumar, Sonali Kotagiri, Renuka Janupally, et al.
Organic & Biomolecular Chemistry|January 9, 2015
Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profilingVariam Ullas Jeankumar, Rudraraju Srilakshmi Reshma, Renuka Janupally, et al.
Pharmacological Reports : PR|June 7, 2014
Oral dosing in adult zebrafish: proof-of-concept using pharmacokinetics and pharmacological evaluation of carbamazepinePushkar Kulkarni, Girish Hari Chaudhari, Vijaykumar Sripuram, et al.
Chemmedchem|June 26, 2014
Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analoguesVariam Ullas Jeankumar, Janupally Renuka, Sonali Kotagiri, et al.
European Journal of Medicinal Chemistry|August 30, 2014
Ligand-free Pd-catalyzed C-N cross-coupling/cyclization strategy: an unprecedented access to 1-thienyl pyrroloquinoxalines for the new approach towards apoptosisSunder Kumar Kolli, Ali Nakhi, Sivakumar Archana, et al.
International Journal of Antimicrobial Agents|January 18, 2014
Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leadsVariam Ullas Jeankumar, Janupally Renuka, Venkat Koushik Pulla, et al.
Pageof 4